JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements
The Japanese Psycho-Oncology Society and Japanese Association of Supportive Care in Cancer recently launched the clinical practice guidelines for delirium in adult cancer patients. The aim of the guidelines was to provide evidence-based recommendations for the clinical assessment and management of d...
Saved in:
| Published in | Japanese journal of clinical oncology Vol. 50; no. 5; pp. 586 - 593 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Oxford University Press
05.05.2020
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1465-3621 0368-2811 1465-3621 |
| DOI | 10.1093/jjco/hyaa003 |
Cover
Loading…
| Abstract | The Japanese Psycho-Oncology Society and Japanese Association of Supportive Care in Cancer recently launched the clinical practice guidelines for delirium in adult cancer patients. The aim of the guidelines was to provide evidence-based recommendations for the clinical assessment and management of delirium in cancer patients. This article reports the process of developing the guideline and summarizes the recommendations made.
The guidelines were developed in accordance with the Medical Information Network Distribution Service creation procedures. The guideline development group, consisting of multidisciplinary members, formulated nine clinical questions. A systematic literature search was conducted to identify relevant articles published prior to through 31 May 2016. Each article was reviewed by two independent reviewers. The level of evidence and the strength of the recommendations were graded using the grading system developed by the Medical Information Network Distribution Service, following the concept of The Grading of Recommendations Assessment, Development and Evaluation system. The modified Delphi method was used to validate the recommendation statements.
This article provides a summary of the recommendations with rationales for each, as well as a short summary.
These guidelines will support the clinical assessment and management of delirium in cancer patients. However, additional clinical studies are warranted to further improve the management of delirium. |
|---|---|
| AbstractList | The Japanese Psycho-Oncology Society and Japanese Association of Supportive Care in Cancer recently launched the clinical practice guidelines for delirium in adult cancer patients. The aim of the guidelines was to provide evidence-based recommendations for the clinical assessment and management of delirium in cancer patients. This article reports the process of developing the guideline and summarizes the recommendations made.BACKGROUNDThe Japanese Psycho-Oncology Society and Japanese Association of Supportive Care in Cancer recently launched the clinical practice guidelines for delirium in adult cancer patients. The aim of the guidelines was to provide evidence-based recommendations for the clinical assessment and management of delirium in cancer patients. This article reports the process of developing the guideline and summarizes the recommendations made.The guidelines were developed in accordance with the Medical Information Network Distribution Service creation procedures. The guideline development group, consisting of multidisciplinary members, formulated nine clinical questions. A systematic literature search was conducted to identify relevant articles published prior to through 31 May 2016. Each article was reviewed by two independent reviewers. The level of evidence and the strength of the recommendations were graded using the grading system developed by the Medical Information Network Distribution Service, following the concept of The Grading of Recommendations Assessment, Development and Evaluation system. The modified Delphi method was used to validate the recommendation statements.METHODSThe guidelines were developed in accordance with the Medical Information Network Distribution Service creation procedures. The guideline development group, consisting of multidisciplinary members, formulated nine clinical questions. A systematic literature search was conducted to identify relevant articles published prior to through 31 May 2016. Each article was reviewed by two independent reviewers. The level of evidence and the strength of the recommendations were graded using the grading system developed by the Medical Information Network Distribution Service, following the concept of The Grading of Recommendations Assessment, Development and Evaluation system. The modified Delphi method was used to validate the recommendation statements.This article provides a summary of the recommendations with rationales for each, as well as a short summary.RESULTSThis article provides a summary of the recommendations with rationales for each, as well as a short summary.These guidelines will support the clinical assessment and management of delirium in cancer patients. However, additional clinical studies are warranted to further improve the management of delirium.CONCLUSIONSThese guidelines will support the clinical assessment and management of delirium in cancer patients. However, additional clinical studies are warranted to further improve the management of delirium. The Japanese Psycho-Oncology Society and Japanese Association of Supportive Care in Cancer launched the guidelines for delirium. This article reports the process of developing the guideline and summarizes the recommendations. The Japanese Psycho-Oncology Society and Japanese Association of Supportive Care in Cancer recently launched the clinical practice guidelines for delirium in adult cancer patients. The aim of the guidelines was to provide evidence-based recommendations for the clinical assessment and management of delirium in cancer patients. This article reports the process of developing the guideline and summarizes the recommendations made. The guidelines were developed in accordance with the Medical Information Network Distribution Service creation procedures. The guideline development group, consisting of multidisciplinary members, formulated nine clinical questions. A systematic literature search was conducted to identify relevant articles published prior to through 31 May 2016. Each article was reviewed by two independent reviewers. The level of evidence and the strength of the recommendations were graded using the grading system developed by the Medical Information Network Distribution Service, following the concept of The Grading of Recommendations Assessment, Development and Evaluation system. The modified Delphi method was used to validate the recommendation statements. This article provides a summary of the recommendations with rationales for each, as well as a short summary. These guidelines will support the clinical assessment and management of delirium in cancer patients. However, additional clinical studies are warranted to further improve the management of delirium. |
| Author | Uchitomi, Yosuke Sasaki, Chiyuki Hasuo, Hideaki Inoue, Shinichiro Wada, Saho Adachi, Hiroyoshi Takeuchi, Mari Okamoto, Yoshiaki Kako, Jun Inada, Shuji Tanimukai, Hitoshi Akizuki, Nobuya Okuyama, Toru Matsuda, Yoshinobu Inagaki, Masatoshi Dotani, Chikako Kishi, Yasuhiro Matsushima, Eisuke Sugano, Koji Yoshimura, Masafumi Fujisawa, Daisuke |
| AuthorAffiliation | 5 Division of Respiratory Medicine , Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan 7 Department of Neuropsychiatry , Kansai Medical University, Moriguchi, Japan 9 Department of Pediatrics , The University of Tokyo Hospital, Tokyo, Japan 21 Division of Psycho-oncology and Palliative Care , Nagoya City University Hospital, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan 15 Nursing Department , National Cancer Center Hospital, Tokyo, Japan 17 Department of Psycho-Oncology/Psychiatry , Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo 113-8677, Japan 1 Department of Psychosomatic Internal Medicine , National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan 8 Department of Psycho-Oncology , National Cancer Center Hospital, Tokyo, Japan 11 Department of Pharmacy , Ashiya Municipal Hospital, Ashiya, Japan 6 Department of Psychosomatic Medicine , Kansai Medical University, Hirakata, Japan 14 Division of Nursing Science , Graduate Schoo |
| AuthorAffiliation_xml | – name: 20 Section of Liaison Psychiatry and Palliative Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo 113-8519, Japan – name: 8 Department of Psycho-Oncology , National Cancer Center Hospital, Tokyo, Japan – name: 6 Department of Psychosomatic Medicine , Kansai Medical University, Hirakata, Japan – name: 11 Department of Pharmacy , Ashiya Municipal Hospital, Ashiya, Japan – name: 1 Department of Psychosomatic Internal Medicine , National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan – name: 19 Innovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital , Tokyo 104-0045, Japan – name: 7 Department of Neuropsychiatry , Kansai Medical University, Moriguchi, Japan – name: 12 Department of Palliative Care , Keio University School of Medicine, Tokyo, Japan – name: 3 Department of Neuropsychiatry , Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science, Okayama, Japan – name: 21 Division of Psycho-oncology and Palliative Care , Nagoya City University Hospital, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan – name: 17 Department of Psycho-Oncology/Psychiatry , Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo 113-8677, Japan – name: 18 Department of Psychiatry, Faculty of Medicine, Shimane University , Izumo 693-8501, Japan – name: 2 Faculty of Human Health Sciences , Graduate School of Medicine, Kyoto University, Kyoto, Japan – name: 5 Division of Respiratory Medicine , Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan – name: 9 Department of Pediatrics , The University of Tokyo Hospital, Tokyo, Japan – name: 16 Department of Psychiatry , Nippon Medical School Musashikosugi Hospital, Kawasaki 211-8533, Japan – name: 10 Sleep Medicine Center , Osaka University Hospital, Suita, Japan – name: 14 Division of Nursing Science , Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan – name: 15 Nursing Department , National Cancer Center Hospital, Tokyo, Japan – name: 4 Department of Psychosomatic Medicine , The University of Tokyo Hospital, Tokyo, Japan – name: 13 Division of Patient Safety , Keio University School of Medicine, Tokyo, Japan |
| Author_xml | – sequence: 1 givenname: Yoshinobu surname: Matsuda fullname: Matsuda, Yoshinobu organization: Department of Psychosomatic Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan – sequence: 2 givenname: Hitoshi surname: Tanimukai fullname: Tanimukai, Hitoshi organization: Faculty of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan – sequence: 3 givenname: Shinichiro surname: Inoue fullname: Inoue, Shinichiro organization: Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science, Okayama, Japan – sequence: 4 givenname: Shuji surname: Inada fullname: Inada, Shuji organization: Department of Psychosomatic Medicine, The University of Tokyo Hospital, Tokyo, Japan – sequence: 5 givenname: Koji surname: Sugano fullname: Sugano, Koji organization: Division of Respiratory Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan – sequence: 6 givenname: Hideaki surname: Hasuo fullname: Hasuo, Hideaki organization: Department of Psychosomatic Medicine, Kansai Medical University, Hirakata, Japan – sequence: 7 givenname: Masafumi surname: Yoshimura fullname: Yoshimura, Masafumi organization: Department of Neuropsychiatry, Kansai Medical University, Moriguchi, Japan – sequence: 8 givenname: Saho surname: Wada fullname: Wada, Saho organization: Department of Psycho-Oncology, National Cancer Center Hospital, Tokyo, Japan – sequence: 9 givenname: Chikako surname: Dotani fullname: Dotani, Chikako organization: Department of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan – sequence: 10 givenname: Hiroyoshi surname: Adachi fullname: Adachi, Hiroyoshi organization: Sleep Medicine Center, Osaka University Hospital, Suita, Japan – sequence: 11 givenname: Yoshiaki surname: Okamoto fullname: Okamoto, Yoshiaki organization: Department of Pharmacy, Ashiya Municipal Hospital, Ashiya, Japan – sequence: 12 givenname: Mari surname: Takeuchi fullname: Takeuchi, Mari organization: Department of Palliative Care, Keio University School of Medicine, Tokyo, Japan – sequence: 13 givenname: Daisuke surname: Fujisawa fullname: Fujisawa, Daisuke organization: Division of Patient Safety, Keio University School of Medicine, Tokyo, Japan – sequence: 14 givenname: Jun surname: Kako fullname: Kako, Jun organization: Division of Nursing Science, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan – sequence: 15 givenname: Chiyuki surname: Sasaki fullname: Sasaki, Chiyuki organization: Nursing Department, National Cancer Center Hospital, Tokyo, Japan – sequence: 16 givenname: Yasuhiro surname: Kishi fullname: Kishi, Yasuhiro organization: Department of Psychiatry, Nippon Medical School Musashikosugi Hospital, Kawasaki 211-8533, Japan – sequence: 17 givenname: Nobuya surname: Akizuki fullname: Akizuki, Nobuya organization: Department of Psycho-Oncology/Psychiatry, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo 113-8677, Japan – sequence: 18 givenname: Masatoshi surname: Inagaki fullname: Inagaki, Masatoshi organization: Department of Psychiatry, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan – sequence: 19 givenname: Yosuke surname: Uchitomi fullname: Uchitomi, Yosuke organization: Innovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital, Tokyo 104-0045, Japan – sequence: 20 givenname: Eisuke surname: Matsushima fullname: Matsushima, Eisuke organization: Section of Liaison Psychiatry and Palliative Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8519, Japan – sequence: 21 givenname: Toru surname: Okuyama fullname: Okuyama, Toru organization: Division of Psycho-oncology and Palliative Care, Nagoya City University Hospital, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32215557$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkc1vGyEQxVGUKl_treeKYw5xDCyw6xwiRVaT1LKUSmnPiGVnHSwWHNiNlP--bO1abtUTg96PecO8c3TsgweEPlNyTcmsmK7XJkxf3rUmpDhCZ5RLMSkko8cH9Sk6T2lNCBEVL0_QacEYFUKUZ8gtvj89Txd3z_M5Ns56a7TDq8E2kC-QcBsiHutohw5bj3UzuB4b7Q1EvNG9Bd-nG6xxGrpOx3ccWhzBhK4D32Q5eJx63UM3ch_Rh1a7BJ925wX6ef_1x_xxsnx6-Da_W04MJ7yftJIXZUuIrCoJdSVnoipKLsqamKYG1jBJmKCtNASElLoi-SucZaWeUWF4XVyg223fzVB30JjsHbVTm2jHEVXQVv2tePuiVuFNlYwwymlucLlrEMPrAKlXnU0GnNMewpAUKyqeQcZFRr8ceu1N_qw4A1dbwMSQUoR2j1CixgTVmKDaJZhx9g9ubP97kXlS6_7_6Be8GqJ- |
| CitedBy_id | crossref_primary_10_1016_j_resinv_2023_01_006 crossref_primary_10_1093_jjco_hyac205 crossref_primary_10_1093_jjco_hyad042 crossref_primary_10_1016_j_jaclp_2024_02_004 crossref_primary_10_1097_NCC_0000000000001330 crossref_primary_10_1016_j_jpainsymman_2022_04_176 crossref_primary_10_2512_jspm_16_261 crossref_primary_10_1002_cam4_5069 crossref_primary_10_1016_j_jpainsymman_2022_03_005 crossref_primary_10_1017_S1478951524000117 |
| Cites_doi | 10.1371/journal.pone.0123090 10.1016/S0163-8343(00)00121-3 10.1111/j.1440-1819.2012.02346.x 10.1200/JCO.2005.05.140 10.1007/s00540-012-1486-3 10.5770/cgj.v14i2.13 10.1176/appi.psy.47.6.471 10.1093/annonc/mdy147 10.1001/jamainternmed.2014.7779 10.1016/S0885-3924(00)00241-4 10.1007/s00520-010-0874-1 10.1002/cncr.24215 10.1097/CCM.0b013e3182783b72 10.1016/j.jpainsymman.2013.10.024 10.1002/1097-0142(20000615)88:12<2859::AID-CNCR29>3.0.CO;2-T 10.1016/S0163-8343(03)00070-7 10.1001/jama.2017.11468 10.1093/jjco/hyn157 10.1016/j.jpainsymman.2004.12.010 10.1001/jamainternmed.2016.7491 10.1007/s005200050259 10.1200/JCO.2012.44.6518 10.1176/appi.psy.43.3.183 10.1001/archinte.160.6.786 10.1016/j.jpainsymman.2010.02.017 10.12968/ijpn.2000.6.8.9060 10.1002/cncr.22665 10.1016/0885-3924(96)00050-4 10.1111/jgs.14076 10.1176/ajp.153.2.231 10.1002/cncr.20712 10.1093/ageing/afl005 10.1177/0269216307081129 10.1093/jjco/hyv100 10.1191/026921601678576185 10.1634/theoncologist.2018-0242 10.1017/S1478951505050479 10.1089/109662103768253669 10.1176/appi.psy.43.3.175 10.1176/jnp.2008.20.2.185 10.1176/appi.books.9780890425596 10.1111/j.1741-6612.2008.00301.x |
| ContentType | Journal Article |
| Copyright | The Author(s) 2020. Published by Oxford University Press. The Author(s) 2020. Published by Oxford University Press. 2020 |
| Copyright_xml | – notice: The Author(s) 2020. Published by Oxford University Press. – notice: The Author(s) 2020. Published by Oxford University Press. 2020 |
| DBID | AAYXX CITATION NPM 7X8 5PM |
| DOI | 10.1093/jjco/hyaa003 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1465-3621 |
| EndPage | 593 |
| ExternalDocumentID | PMC7202141 32215557 10_1093_jjco_hyaa003 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: ; grantid: 19EA1009 |
| GroupedDBID | --- -E4 .2P .I3 .ZR 0R~ 18M 1TH 29J 2WC 4.4 482 48X 5GY 5RE 5VS 5WA 5WD 70D AABZA AACZT AAJKP AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAYXX ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABNHQ ABNKS ABPQP ABPTD ABQLI ABQNK ABVGC ABWST ABXVV ABZBJ ACGFO ACGFS ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFRAH AFXAL AGINJ AGKEF AGORE AGQXC AGSYK AGUTN AHGBF AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CDBKE CITATION CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBS EE~ EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IH2 IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN M-Z MHKGH ML0 N9A NGC NOMLY NOYVH O9- OAUYM OAWHX OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y RD5 ROX ROZ RUSNO RW1 RXO TCURE TEORI TJX TR2 W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 ADJQC ADRIX AFXEN M49 NPM RHF 7X8 5PM |
| ID | FETCH-LOGICAL-c404t-f6437f006886eb8695837457b0cdbe2d260251f6c0e566a8055542be2b915c4b3 |
| ISSN | 1465-3621 0368-2811 |
| IngestDate | Thu Aug 21 14:14:30 EDT 2025 Thu Jul 10 23:44:16 EDT 2025 Wed Feb 19 02:31:31 EST 2025 Tue Jul 01 04:35:29 EDT 2025 Thu Apr 24 23:02:18 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | cancer palliative care delirium psycho-oncology guideline |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc/4.0 The Author(s) 2020. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c404t-f6437f006886eb8695837457b0cdbe2d260251f6c0e566a8055542be2b915c4b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7202141 |
| PMID | 32215557 |
| PQID | 2384214245 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7202141 proquest_miscellaneous_2384214245 pubmed_primary_32215557 crossref_primary_10_1093_jjco_hyaa003 crossref_citationtrail_10_1093_jjco_hyaa003 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-May-05 |
| PublicationDateYYYYMMDD | 2020-05-05 |
| PublicationDate_xml | – month: 05 year: 2020 text: 2020-May-05 day: 05 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Japanese journal of clinical oncology |
| PublicationTitleAlternate | Jpn J Clin Oncol |
| PublicationYear | 2020 |
| Publisher | Oxford University Press |
| Publisher_xml | – name: Oxford University Press |
| References | Association AP (2020050701580349000_ref1) 2013 Siddiqi (2020050701580349000_ref42) 2006; 35 Meagher (2020050701580349000_ref15) 2008; 20 Morita (2020050701580349000_ref37) 2003; 6 Morita (2020050701580349000_ref31) 2005; 30 Bruera (2020050701580349000_ref45) 2013; 31 Lawlor (2020050701580349000_ref12) 2000; 88 Breitbart (2020050701580349000_ref4) 2002; 43 Bosisio (2020050701580349000_ref14) 2006; 47 Breitbart (2020050701580349000_ref27) 2002; 43 Agar (2020050701580349000_ref24) 2017; 177 Hshieh (2020050701580349000_ref41) 2015; 175 Morita (2020050701580349000_ref16) 2001; 15 Chizuko Takigawa (2020050701580349000_ref36) 2009; 6 Akira Watanabe (2020050701580349000_ref28) 2016; 23 Gagnon (2020050701580349000_ref34) 1999; 7 Leonard (2020050701580349000_ref17) 2014; 48 Neufeld (2020050701580349000_ref29) 2016; 64 Kishi (2020050701580349000_ref25) 2012; 66 Cerchietti (2020050701580349000_ref44) 2000; 6 Tropea (2020050701580349000_ref6) 2008; 27 Okuyama (2020050701580349000_ref11) 2019; 24 Lawlor (2020050701580349000_ref3) 2000; 160 Bruera (2020050701580349000_ref5) 2009; 115 Moryl (2020050701580349000_ref32) 2005; 3 Tatematsu (2020050701580349000_ref38) 2011; 19 Abraha (2020050701580349000_ref39) 2015; 10 Elsayem (2020050701580349000_ref26) 2010; 40 Brajtman (2020050701580349000_ref7) 2011; 14 Matsuoka (2020050701580349000_ref18) 2001; 23 Uchida (2020050701580349000_ref2) 2015; 45 Barr (2020050701580349000_ref8) 2013; 41 Sagawa (2020050701580349000_ref22) 2009; 39 Maddocks (2020050701580349000_ref35) 1996; 12 Britton (2020050701580349000_ref40) 2004; 2 Gaudreau (2020050701580349000_ref20) 2007; 109 Kato (2020050701580349000_ref19) 2010; 51 Breitbart (2020050701580349000_ref30) 1996; 153 Grassi (2020050701580349000_ref13) 2001; 21 Tatsuya Morita (2020050701580349000_ref23) 1998; 40 Gaudreau (2020050701580349000_ref9) 2005; 23 Hui (2020050701580349000_ref43) 2017; 318 Bush (2020050701580349000_ref10) 2018; 29 Namba (2020050701580349000_ref47) 2007; 21 Ljubisavljevic (2020050701580349000_ref21) 2003; 25 Benitez-Rosario (2020050701580349000_ref33) 2004; 101 Arai (2020050701580349000_ref46) 2013; 27 |
| References_xml | – volume: 10 start-page: e0123090 year: 2015 ident: 2020050701580349000_ref39 article-title: Efficacy of non-pharmacological interventions to prevent and treat delirium in older patients: a systematic overview. The SENATOR project ONTOP series publication-title: PLoS One doi: 10.1371/journal.pone.0123090 – volume: 23 start-page: 36 year: 2001 ident: 2020050701580349000_ref18 article-title: Clinical utility and validation of the Japanese version of memorial delirium assessment scale in a psychogeriatric inpatient setting publication-title: Gen Hosp Psychiatry doi: 10.1016/S0163-8343(00)00121-3 – volume: 66 start-page: 411 year: 2012 ident: 2020050701580349000_ref25 article-title: Treatment of delirium with risperidone in cancer patients publication-title: Psychiatry Clin Neurosci doi: 10.1111/j.1440-1819.2012.02346.x – volume: 23 start-page: 6712 year: 2005 ident: 2020050701580349000_ref9 article-title: Psychoactive medications and risk of delirium in hospitalized cancer patients publication-title: J Clin Oncol doi: 10.1200/JCO.2005.05.140 – volume: 27 start-page: 88 year: 2013 ident: 2020050701580349000_ref46 article-title: Neurolytic celiac plexus block reduces occurrence and duration of terminal delirium in patients with pancreatic cancer publication-title: J Anesth doi: 10.1007/s00540-012-1486-3 – volume: 14 start-page: 40 year: 2011 ident: 2020050701580349000_ref7 article-title: Developing guidelines on the assessment and treatment of delirium in older adults at the end of life publication-title: Can Geriatr J doi: 10.5770/cgj.v14i2.13 – volume: 2 start-page: CD000395 year: 2004 ident: 2020050701580349000_ref40 article-title: Multidisciplinary team interventions for delirium in patients with chronic cognitive impairment publication-title: Cochrane Database Syst Rev – volume: 47 start-page: 471 year: 2006 ident: 2020050701580349000_ref14 article-title: Phenomenology of delirium in cancer patients, as described by the memorial delirium assessment scale (MDAS) and the delirium rating scale (DRS) publication-title: Psychosomatics doi: 10.1176/appi.psy.47.6.471 – volume: 23 start-page: 277 year: 2016 ident: 2020050701580349000_ref28 article-title: Effectiveness of treatment using quetiapine for delirium in palliative care publication-title: Jpn J Gen Hosp Psychiatry – volume: 29 start-page: iv143 year: 2018 ident: 2020050701580349000_ref10 article-title: Delirium in adult cancer patients: ESMO clinical practice guidelines publication-title: Ann Oncol doi: 10.1093/annonc/mdy147 – volume: 175 start-page: 512 year: 2015 ident: 2020050701580349000_ref41 article-title: Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2014.7779 – volume: 21 start-page: 59 year: 2001 ident: 2020050701580349000_ref13 article-title: Assessing delirium in cancer patients: the Italian versions of the delirium rating scale and the memorial delirium assessment scale publication-title: J Pain Symptom Manag doi: 10.1016/S0885-3924(00)00241-4 – volume: 19 start-page: 765 year: 2011 ident: 2020050701580349000_ref38 article-title: The effects of exercise therapy on delirium in cancer patients: a retrospective study publication-title: Support Care Cancer doi: 10.1007/s00520-010-0874-1 – volume: 115 start-page: 2004 year: 2009 ident: 2020050701580349000_ref5 article-title: Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers publication-title: Cancer doi: 10.1002/cncr.24215 – volume: 41 start-page: 263 year: 2013 ident: 2020050701580349000_ref8 article-title: Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit publication-title: Crit Care Med doi: 10.1097/CCM.0b013e3182783b72 – volume: 48 start-page: 176 year: 2014 ident: 2020050701580349000_ref17 article-title: Practical assessment of delirium in palliative care publication-title: J Pain Symptom Manag doi: 10.1016/j.jpainsymman.2013.10.024 – volume: 88 start-page: 2859 year: 2000 ident: 2020050701580349000_ref12 article-title: Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer: assessing delirium in advanced cancer publication-title: Cancer doi: 10.1002/1097-0142(20000615)88:12<2859::AID-CNCR29>3.0.CO;2-T – volume: 25 start-page: 345 year: 2003 ident: 2020050701580349000_ref21 article-title: Risk factors for development of delirium among oncology patients publication-title: Gen Hosp Psychiatry doi: 10.1016/S0163-8343(03)00070-7 – volume: 318 start-page: 1047 year: 2017 ident: 2020050701580349000_ref43 article-title: Effect of Lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care: a randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2017.11468 – volume: 39 start-page: 175 year: 2009 ident: 2020050701580349000_ref22 article-title: Etiologies of delirium and their relationship to reversibility and motor subtype in cancer patients publication-title: Jpn J Clin Oncol doi: 10.1093/jjco/hyn157 – volume: 30 start-page: 96 year: 2005 ident: 2020050701580349000_ref31 article-title: Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial publication-title: J Pain Symptom Manag doi: 10.1016/j.jpainsymman.2004.12.010 – volume: 177 start-page: 34 year: 2017 ident: 2020050701580349000_ref24 article-title: Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2016.7491 – volume: 7 start-page: 265 year: 1999 ident: 2020050701580349000_ref34 article-title: The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain publication-title: Support Care Cancer doi: 10.1007/s005200050259 – volume: 31 start-page: 111 year: 2013 ident: 2020050701580349000_ref45 article-title: Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial publication-title: J Clin Oncol doi: 10.1200/JCO.2012.44.6518 – volume: 43 start-page: 183 year: 2002 ident: 2020050701580349000_ref4 article-title: The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses publication-title: Psychosomatics doi: 10.1176/appi.psy.43.3.183 – volume: 160 start-page: 786 year: 2000 ident: 2020050701580349000_ref3 article-title: Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study publication-title: Arch Intern Med doi: 10.1001/archinte.160.6.786 – volume: 40 start-page: 774 year: 2010 ident: 2020050701580349000_ref26 article-title: Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study publication-title: J Pain Symptom Manag doi: 10.1016/j.jpainsymman.2010.02.017 – volume: 6 start-page: 370 year: 2000 ident: 2020050701580349000_ref44 article-title: Hypodermoclysis for control of dehydration in terminal-stage cancer publication-title: Int J Palliat Nurs doi: 10.12968/ijpn.2000.6.8.9060 – volume: 40 start-page: 823 year: 1998 ident: 2020050701580349000_ref23 article-title: The risk factors for delirium in terminal cancer patients: a prospective study publication-title: J Clin Psychiatry – volume: 109 start-page: 2365 year: 2007 ident: 2020050701580349000_ref20 article-title: Opioid medications and longitudinal risk of delirium in hospitalized cancer patients publication-title: Cancer doi: 10.1002/cncr.22665 – volume: 12 start-page: 182 year: 1996 ident: 2020050701580349000_ref35 article-title: Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone publication-title: J Pain Symptom Manag doi: 10.1016/0885-3924(96)00050-4 – volume: 64 start-page: 705 year: 2016 ident: 2020050701580349000_ref29 article-title: Antipsychotic medication for prevention and treatment of delirium in hospitalized adults: a systematic review and meta-analysis publication-title: J Am Geriatr Soc doi: 10.1111/jgs.14076 – volume: 153 start-page: 231 year: 1996 ident: 2020050701580349000_ref30 article-title: A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients publication-title: Am J Psychiatry doi: 10.1176/ajp.153.2.231 – volume: 101 start-page: 2866 year: 2004 ident: 2020050701580349000_ref33 article-title: Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain publication-title: Cancer doi: 10.1002/cncr.20712 – volume: 35 start-page: 350 year: 2006 ident: 2020050701580349000_ref42 article-title: Occurrence and outcome of delirium in medical in-patients: a systematic literature review publication-title: Age Ageing doi: 10.1093/ageing/afl005 – volume: 21 start-page: 587 year: 2007 ident: 2020050701580349000_ref47 article-title: Terminal delirium: families' experience publication-title: Palliat Med doi: 10.1177/0269216307081129 – volume: 6 start-page: 557 year: 2009 ident: 2020050701580349000_ref36 article-title: Efficacy of partial opioid rotation of morphine to intravenous compound oxycodone for morphine-induced delirium in advanced cancer patients publication-title: JJSPC – volume: 45 start-page: 934 year: 2015 ident: 2020050701580349000_ref2 article-title: Prevalence, course and factors associated with delirium in elderly patients with advanced cancer: a longitudinal observational study publication-title: Jpn J Clin Oncol doi: 10.1093/jjco/hyv100 – volume: 15 start-page: 197 year: 2001 ident: 2020050701580349000_ref16 article-title: Communication capacity scale and agitation distress scale to measure the severity of delirium in terminally ill cancer patients: a validation study publication-title: Palliat Med doi: 10.1191/026921601678576185 – volume: 24 start-page: e574 year: 2019 ident: 2020050701580349000_ref11 article-title: Current pharmacotherapy does not improve severity of hypoactive delirium in patients with advanced cancer: pharmacological audit study of safety and efficacy in real world (phase-R) publication-title: Oncologist doi: 10.1634/theoncologist.2018-0242 – volume: 3 start-page: 311 year: 2005 ident: 2020050701580349000_ref32 article-title: Methadone in the treatment of pain and terminal delirum in advanced cancer patients publication-title: Palliat Support Care doi: 10.1017/S1478951505050479 – volume: 6 start-page: 557 year: 2003 ident: 2020050701580349000_ref37 article-title: Agitated terminal delirium and association with partial opioid substitution and hydration publication-title: J Palliat Med doi: 10.1089/109662103768253669 – volume: 43 start-page: 175 year: 2002 ident: 2020050701580349000_ref27 article-title: An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients publication-title: Psychosomatics doi: 10.1176/appi.psy.43.3.175 – volume: 20 start-page: 185 year: 2008 ident: 2020050701580349000_ref15 article-title: A new data-based motor subtype schema for delirium publication-title: J Neuropsychiatry Clin Neurosci doi: 10.1176/jnp.2008.20.2.185 – volume: 51 start-page: 425 year: 2010 ident: 2020050701580349000_ref19 article-title: Japanese version of the delirium rating scale, revised-98 (DRS-R98-J): reliability and validity publication-title: Psychosomatics – volume-title: Diagnostic and Statistical Manual of Mental Disorders, 5th edn: DSM-5 year: 2013 ident: 2020050701580349000_ref1 doi: 10.1176/appi.books.9780890425596 – volume: 27 start-page: 150 year: 2008 ident: 2020050701580349000_ref6 article-title: Clinical practice guidelines for the management of delirium in older people in Australia publication-title: Australas J Ageing doi: 10.1111/j.1741-6612.2008.00301.x |
| SSID | ssj0005847 |
| Score | 2.3240106 |
| Snippet | The Japanese Psycho-Oncology Society and Japanese Association of Supportive Care in Cancer recently launched the clinical practice guidelines for delirium in... The Japanese Psycho-Oncology Society and Japanese Association of Supportive Care in Cancer launched the guidelines for delirium. This article reports the... |
| SourceID | pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 586 |
| SubjectTerms | Original |
| Title | JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/32215557 https://www.proquest.com/docview/2384214245 https://pubmed.ncbi.nlm.nih.gov/PMC7202141 |
| Volume | 50 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkKa9IL4pXzISPE2haWKnKW9TAZWhAlI3aTxFsePQlCWZ2uQB_gX-ae5s56Mbk4CXNIpTu-r9fL6z735HyEuXCREGKnZU6iuHSZk4YIVMnTDxwlj6gqcMc4cXn4L5KTs-42eDwa9e1FJdidfy5x_zSv5HqvAM5IpZsv8g2bZTeAD3IF-4goTh-lcyPv7yeYk1lo-Ws1mX4_itRuoqDGfXMYR4v8nqHHc2NNsGBnpJtWkoVbcm39lmsaHxiE5ynitbbulQ5xzlDedTa8nCKovVK_vcE-1PKAu5s12_iKttnWg79WuJm16lqLs9gyLL6--mLPYcFAy0t4Atytrska-w51W2Kbum2HS4XNXrrL954elzd9ecYiujcFnAHVhEx32NbKhoLfJ4T71yQ5t9Re0bSqz1WpbwsfoRx64mTqh6GLjINQhAf4EFZTixLxFtN003yE0PfA4sh_H2w8cuXgjWcZs5AcONcLCRHeqA7Ddf3jVvrvgsl0Nve7bMyW1yyzoh9Mgg6g4ZqOIu2V_YMIt75ByBNdKwoo1MaQcrCrCiDaxoVlANK2pgRRtYvaExtaCiZUp3QUU7UN0np-_fnczmji3L4UjmsspJ8aw3xdwimOQw0ac89CeMT4QrE6G8BDxkMJrTQLoKfIU4REo55kGLmI65ZMJ_QPaKslCPCFVBmE5cFQZjETLugfftu0mqZJzwaQqrzZAcNv9mJC1nPZZOOY9M7IQfoRgiK4YhedW-fWG4Wq5570UjmAiUKZ6QwYQp620E9itDDkLGh-ShEVTbUyPhIZnsiLB9AYnad1uKbKUJ2yceMhOOH1_b5xNy0M2Op2Sv2tTqGRi7lXiuQfgbw4SzLg |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=JPOS%2FJASCC+clinical+guidelines+for+delirium+in+adult+cancer+patients%3A+a+summary+of+recommendation+statements&rft.jtitle=Japanese+journal+of+clinical+oncology&rft.au=Matsuda%2C+Yoshinobu&rft.au=Tanimukai%2C+Hitoshi&rft.au=Inoue%2C+Shinichiro&rft.au=Inada%2C+Shuji&rft.date=2020-05-05&rft.eissn=1465-3621&rft.volume=50&rft.issue=5&rft.spage=586&rft_id=info:doi/10.1093%2Fjjco%2Fhyaa003&rft_id=info%3Apmid%2F32215557&rft.externalDocID=32215557 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-3621&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-3621&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-3621&client=summon |